Clinical

Dataset Information

0

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA


ABSTRACT: This purpose of this study is to investigate whether the number and size of rectal polyps can be reduced in patients with Familial Adenomatous Polyposis (FAP) by using a highly-purified form of a naturally occurring substance, the omega-3 fatty acid, eicosapentaenoic acid (EPA).

DISEASE(S): Fap,Adenomatous Polyposis Coli,Colorectal Neoplasms,Familial Adenomatous Polyposis Coli,Nasopharyngeal Neoplasms

PROVIDER: 2042795 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2085057 | ecrin-mdr-crc
2016-03-16 | GSE79266 | GEO
2022-10-13 | GSE215224 | GEO
2020-02-03 | GSE128472 | GEO
2019-05-04 | GSE130673 | GEO
2016-03-16 | E-GEOD-79266 | biostudies-arrayexpress
2008-10-21 | E-GEOD-12028 | biostudies-arrayexpress
2020-12-31 | GSE124584 | GEO
2020-12-21 | GSE149307 | GEO
2023-04-13 | GSE153648 | GEO